Formulation of a thienopyridine platelet aggregation inhibitor

Details for Australian Patent Application No. 2006258102 (hide)

Owner Eli Lilly and Company

Inventors Ternik, Robert Louis; Oren, Peter Lloyd; Dziennik, David Brian; Edelman, Tamara Beth

Agent Spruson & Ferguson

Pub. Number AU-B-2006258102

PCT Pub. Number WO2006/135605

Priority 60/689,183 10.06.05 US

Filing date 6 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 15 September 2011

International Classifications

A61K 31/4365 (2006.01)

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/135605 Priority application(s): WO2006/135605

15 September 2011 Application Accepted

  Published as AU-B-2006258102

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258109-Method for monitoring organic deposits in papermaking

2006258101-Inhibitors of checkpoint kinases